These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34158840)

  • 1. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
    Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
    Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
    Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
    Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
    Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
    J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
    Miller SE; Tummers WS; Teraphongphom N; van den Berg NS; Hasan A; Ertsey RD; Nagpal S; Recht LD; Plowey ED; Vogel H; Harsh GR; Grant GA; Li GH; Rosenthal EL
    J Neurooncol; 2018 Aug; 139(1):135-143. PubMed ID: 29623552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
    Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers.
    Bhattacharyya S; Patel N; Wei L; Riffle LA; Kalen JD; Hill GC; Jacobs PM; Zinn KR; Rosenthal E
    Medchemcomm; 2014 Sep; 5(9):1337-1346. PubMed ID: 25431648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sentinel Margin: Intraoperative
    van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
    Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery.
    Lee JY; Thawani JP; Pierce J; Zeh R; Martinez-Lage M; Chanin M; Venegas O; Nims S; Learned K; Keating J; Singhal S
    Neurosurgery; 2016 Dec; 79(6):856-871. PubMed ID: 27741220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-guided craniotomy of glioblastoma using panitumumab-IRDye800.
    Zhou Q; Li G
    Neurosurg Focus Video; 2022 Jan; 6(1):V9. PubMed ID: 36284595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
    Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
    Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
    Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
    Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.
    Patil CG; Walker DG; Miller DM; Butte P; Morrison B; Kittle DS; Hansen SJ; Nufer KL; Byrnes-Blake KA; Yamada M; Lin LL; Pham K; Perry J; Parrish-Novak J; Ishak L; Prow T; Black K; Mamelak AN
    Neurosurgery; 2019 Oct; 85(4):E641-E649. PubMed ID: 31069381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
    Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
    Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.
    Pal R; Hom ME; van den Berg NS; Lwin TM; Lee YJ; Prilutskiy A; Faquin W; Yang E; Saladi SV; Varvares MA; Rosenthal EL; Kumar ATN
    Clin Cancer Res; 2022 Jun; 28(11):2373-2384. PubMed ID: 35302604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.